Abstract:Background The association between blood pressure (BP) control and incident diabetes mellitus remains unknown. We aim to investigate the association between degree of time‐averaged on‐treatment systolic blood pressure (SBP) control and incident diabetes mellitus in hypertensive adults. Methods and Results A total of 14 978 adults with hypertension without diabetes mellitus at baseline were included from the CSPPT (China Stroke Primary Prevention Trial). Participants were randomized double‐masked to daily enalapril 10 mg and folic acid 0.8 mg or enalapril 10 mg alone. BP measurements were taken every 3 months after randomization. The primary outcome was incident diabetes mellitus, defined as physician‐diagnosed diabetes mellitus, or use of glucose‐lowering drugs during follow‐up, or fasting glucose ≥126 mg/dL at the exit visit. Over a median of 4.5 years, a significantly higher risk of incident diabetes mellitus was found in participants with time‐averaged on‐treatment SBP 130 to <140 mm Hg (10.3% versus 7.4%; odds ratio [OR], 1.37; 95% CI, 1.15‒1.64), compared with those with SBP 120 to <130 mm Hg. Moreover, the risk of incident diabetes mellitus increased by 24% (OR, 1.24; 95% CI, 1.00‒1.53) and the incidence of regression to normal fasting glucose (<100 mg/dL) decreased by 29% (OR, 0.71; 95% CI, 0.57‒0.89) in participants with intermediate BP control (SBP/diastolic blood pressure, 130 to <140 and/or 80 to <90 mm Hg), compared with those with a tight BP control of <130/<80 mm Hg. Similar results were found when the time‐averaged BP were calculated using the BP measurements during the first 6‐ or 24‐month treatment period, or in the analysis using propensity scores. Conclusions In this non‐diabetic, hypertensive population, SBP control in the range of 120 to <130 mm Hg, compared with the 130 to <140 mm Hg, was associated with a lower risk of incident diabetes mellitus. Nonstandard Abbreviations and Acronyms CSPPT China Stroke Primary Prevention Trial FG fasting glucose OR odds ratio Clinical Perspective What Is New? This is the first and largest study to investigate the association between degree of systolic blood pressure/diastolic blood pressure control and risk of incident diabetes mellitus in patients with hypertension without baseline diabetes mellitus. It demonstrated that in hypertensive population, systolic blood pressure control in the range of 120 to <130 mm Hg, compared with the 130 to <140 mm Hg, was associated with a lower risk of incident diabetes mellitus. What Are the Clinical Implications? To date, what constitutes optimal blood pressure target with regards to future risk of metabolic diseases remains uncertain. This study represents one step towards filling these critical knowledge gaps. If further confirmed, our findings would have important implications for clinical practice and guidelines. Our results support the adoption of a tight systolic blood pressure goal in general patients with hypertension for preventing incident diabetes mellitus. According to data from the International Diabetes Federation, the global prevalence of diabetes mellitus in adults was estimated to be 8.8% in 2015 and is predicted to rise to 10.4% by 2040. 1 Diabetes mellitus can lead to several health complications, including cardiovascular diseases, renal dysfunction, amputation, and vision problems. 2 Therefore, primary prevention of diabetes mellitus is critically important to reduce population burden of diabetes mellitus and its serious consequences. Hypertension is a well‐established major modifiable risk factor for cardiovascular diseases, peripheral artery disease, and renal diseases. 2 , 3 Although hypertension is common in patients with type 2 diabetes mellitus, 4 its role in the development of diabetes mellitus is uncertain. Several longitudinal studies showed that subjects with baseline hyp -Abstract Truncated-

Impact of Hypertension Duration on the Cardiovascular Benefit of Intensive Blood Pressure Control

Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study

Effects Of Intensive Antihypertensive Treatment On Chinese Hypertensive Patients Older Than 70years

Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients

Intensified Antihypertensive Therapy and Blood Pressure Variability in Older Than 70 of Chinese Hypertensive Patients

Longitudinal Change in Blood Pressure is Associated with Cardiovascular Disease Mortality in a Chinese Cohort.

Improving outcomes for older hypertensive patients: is more intensive treatment better?

Intensive Blood Pressure Lowering Improves Left Ventricular Hypertrophy in Older Patients with Hypertension: The STEP Trial

Achieved systolic blood pressure and cardiovascular outcomes in 60–80-year-old patients: the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial

Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension

Impact of Achieved Blood Pressure on First Stroke in Uncomplicated Grade 1 Hypertension.

Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events

ANTIHYPERTENSIVE TREATMENT OF MASKED HYPERTENSION GUIDED BY AMBULATORY BLOOD PRESSURE MONITORING: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control project

Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension

Degree of Blood Pressure Control and Incident Diabetes Mellitus in Chinese Adults With Hypertension.

The Impacts of Premorbid Hypertension Treatment on Functional Outcomes of Ischemic Stroke

[Study on the Associations of Meeting Intensive Systolic Blood Pressure Control Goals with Risk for Incident Cardiovascular and Cerebrovascular Diseases among the Adult Hypertensive Patients in China].

Optimal Antihypertensive Systolic Blood Pressure: A Systematic Review and Meta-Analysis

Association between encounter frequency and time to blood pressure control among patients with newly diagnosed hypertension: a retrospective cohort study

Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial